Turn Therapeutics Inc. (TTRX) — insider trading
Health Care · NASDAQ
Turn Therapeutics Inc. (TTRX) has 14 reported SEC Form 4 insider transactions in our data, including 1 open-market purchase among the most recent 14 (latest 2026-06-04).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-04 | Kester Kent Edward | Director | Grant / award / vesting (derivative) | 83,334 | — | $0 | Form 4 |
| 2026-06-04 | GOLDEN ARTHUR F | Director | Grant / award / vesting (derivative) | 89,584 | — | $0 | Form 4 |
| 2026-06-04 | Gengos Andrew | Director | Grant / award / vesting (derivative) | 95,000 | — | $0 | Form 4 |
| 2026-06-04 | Dewhurst Martin William | Director | Grant / award / vesting (derivative) | 71,666 | — | $0 | Form 4 |
| 2026-05-28 | Burnam Bradley Evan; BEB Holdings, LLC | Director, Officer (Chief Executive Officer), 10% owner | Bona fide gift | 300,000 | — | $0 | Form 4 |
| 2026-05-28 | Burnam Bradley Evan; BEB Holdings, LLC | Director, Officer (Chief Executive Officer), 10% owner | Bona fide gift | 300,000 | — | $0 | Form 4 |
| 2026-05-28 | Burnam Bradley Evan; BEB Holdings, LLC | Director, Officer (Chief Executive Officer), 10% owner | Bona fide gift | 300,000 | — | $0 | Form 4 |
| 2026-05-28 | Burnam Bradley Evan; BEB Holdings, LLC | Director, Officer (Chief Executive Officer), 10% owner | Bona fide gift | 300,000 | — | $0 | Form 4 |
| 2026-04-02 | GOLDEN ARTHUR F | Director | Bona fide gift | 300,000 | — | $0 | Form 4 |
| 2026-04-02 | Burnam Bradley Evan; BEB Holdings, LLC | Director, Officer (Chief Executive Officer), 10% owner | Bona fide gift | 300,000 | — | $0 | Form 4 |
| 2026-04-01 | Chaudhary Zuraiz | Officer (See Remarks) | Grant / award / vesting (derivative) | 80,000 | — | $0 | Form 4 |
| 2026-04-01 | Burnam Bradley Evan; BEB Holdings, LLC | Director, Officer (Chief Executive Officer), 10% owner | Grant / award / vesting (derivative) | 160,000 | — | $0 | Form 4 |
| 2026-01-07 | Dewhurst Martin William | Director | Grant / award / vesting | 21,882 | — | $0 | Form 4 |
| 2025-12-12 | Chaudhary Zuraiz | Officer (See Remarks) | Open-market purchase | 2,500 | $3.50 | $8.8K | Form 4 |
Ask the chat about TTRX's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: Turn Therapeutics Inc. (TTRX).
Last updated 2026-06-04 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.